TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22104563

Group type: EXPERIMENTAL
Intervention: Single-incision laparoscopic colectomy (SILC)
Number of subjects: 330

Group type: COMPARATOR
Intervention: Multiport laparoscopic colectomy (MLC)
Number of subjects: 330
Study: 20577923

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) for 10 days perioperation (7 days preoperatively and 3 days postoperatively)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non total parenteral nutrition (NTPN)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 120
Study: 17500306

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study: 15331030

Group type: EXPERIMENTAL
Intervention: Internet advertisement with rational appeal and high product involvement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Internet advertisement with emotional appeal and high product involvement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Internet advertisement with rational appeal and low product involvement
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Internet advertisement with emotional appeal and low product involvement
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 120
Study: 11771856

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group (volunteers)
Number of subjects: 26
Study: 9394531

Group type: EXPERIMENTAL
Intervention: IM 10 micrograms
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: ID 2 micrograms
Number of subjects: 359

Group type: COMPARATOR
Intervention: IM 20 micrograms
Number of subjects: 359
Study: 7960442

Group type: EXPERIMENTAL
Intervention: Capillary microscopy, transcutaneous oximetry (tcpO2), and laser Doppler fluxmetry
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Transcutaneous oxygen pressure measurements at rest
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Ankle and toe pressure measurements
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Microcirculatory parameters and techniques
Number of subjects: 130
Study: 3593896

Group type: EXPERIMENTAL
Intervention: Quinidine sulfate controlled release (600 mg day-1 for 4 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quinidine gluconate controlled release (600 mg day-1 for 4 days)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Quinidine sulfate extended-release (300 mg q12h)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Quinidine sulfate in solution (150 mg q6h)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Quinidine gluconate controlled-release (q12h)
Number of subjects: 24
Study: 29158180

Group type: EXPERIMENTAL
Intervention: Left lateral tilt-down position (LTDP)
Number of subjects: 258
Study: 27443598

Group type: EXPERIMENTAL
Intervention: Sarcosine (0.03 g/kg/day)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 25585502

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine 0.25% + 1 μg/kg Dex (GIII)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intraperitoneal saline (GI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intraperitoneal bupivacaine 0.25% (GII)
Number of subjects: 45
Study: 23602770

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg daily)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Prasugrel (10 mg daily)
Number of subjects: 110
Study: 20606091

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus bevacizumab
Number of subjects: 602

Group type: COMPARATOR
Intervention: Gemcitabine plus placebo
Number of subjects: 602
Study: 19038771

Group type: EXPERIMENTAL
Intervention: Pregabalin, 300 mg single oral dose
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Morphine, 10 mg IV
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diphenhydramine, 50 mg oral dose
Number of subjects: 20

Group type: COMPARATOR
Intervention: True placebo
Number of subjects: 20
Study: 16803605

Group type: EXPERIMENTAL
Intervention: 7-day ranitidine bismuth citrate-based triple therapy (ranitidine bismuth citrate + amoxicillin + clarithromycin)
Number of subjects: 206

Group type: COMPARATOR
Intervention: 4-day ranitidine bismuth citrate-based triple therapy (ranitidine bismuth citrate + amoxicillin + clarithromycin)
Number of subjects: 206
Study: 12784408

Group type: EXPERIMENTAL
Intervention: Physiotherapy intervention (education, quadriceps and functional exercises, patellar taping) delivered in nine 30-minute sessions over 10 weeks.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Standard non-physiotherapy treatment (control group).
Number of subjects: 87
Study: 10355237

Group type: EXPERIMENTAL
Intervention: Selective review of photographs relating to previously experienced events
Number of subjects: 0

Group type: COMPARATOR
Intervention: No review of photographs
Number of subjects: 0
Study: 8950732

Group type: EXPERIMENTAL
Intervention: Leboyer method (cord clamping after 3 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Early cord clamping (< 10s)
Number of subjects: 30
Study: 1837130

Group type: COMPARATOR
Intervention: UW solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SLF Cochin
Number of subjects: 0
Study: 6290228

Group type: EXPERIMENTAL
Intervention: Ceruletide (CRL) 2 ng kg‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ceruletide (CRL) 4 ng kg‐1
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ceruletide (CRL)
Number of subjects: 8
Study: 30057908

Group type: EXPERIMENTAL
Intervention: Intramuscular injection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intradermal microdroplet injection
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nanomicroneedle delivery
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intradermal microdroplet group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (Intramuscular injection)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 26842133

Group type: EXPERIMENTAL
Intervention: Internet-delivered weight loss intervention
Number of subjects: 107

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 107
Study: 24886206

Group type: EXPERIMENTAL
Intervention: 3-year school-based multi-component intervention including smoke-free school premises, parental involvement, and a curricular component.
Number of subjects: 4468

Group type: COMPARATOR
Intervention: Control group (43 schools) with no intervention specified.
Number of subjects: 4468
Study: 22382596

Group type: EXPERIMENTAL
Intervention: AVAPS
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fixed-level PS
Number of subjects: 50
Study: 20592434

Group type: EXPERIMENTAL
Intervention: Postcard intervention (six postcards mailed over 12 months)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 18372153

Group type: EXPERIMENTAL
Intervention: Compression stockings
Number of subjects: 169

Group type: COMPARATOR
Intervention: Control (no compression stockings)
Number of subjects: 169
Study: 15779527

Group type: EXPERIMENTAL
Intervention: Low working-memory span group
Number of subjects: 0

Group type: COMPARATOR
Intervention: High working-memory span group
Number of subjects: 0
Study: 11941946

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg bd and Amoxicillin 1 g bd (LA)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg bd and Amoxicillin 1 g bd (OA)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg bd, Amoxicillin 1 g bd and Clarithromycin 500 mg bd (LAC)
Number of subjects: 177
Study: 9921806

Group type: EXPERIMENTAL
Intervention: Daclizumab (1.0 mg/kg every other week for five doses)
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275
Study: 7573900

Group type: EXPERIMENTAL
Intervention: Neurolept-anaesthesia (NLA)
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Balanced anaesthesia (BAL)
Number of subjects: 1318

Group type: EXPERIMENTAL
Intervention: Intravenous propofol anaesthesia (IVA)
Number of subjects: 1318

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1318
Study: 2304255

Group type: EXPERIMENTAL
Intervention: GOE anesthesia and 0.2 mg epidural Bn every three hours (group B)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: GOE anesthesia and 0.2 mg epidural Bn every six hours (group C)
Number of subjects: 63

Group type: COMPARATOR
Intervention: GOE anesthesia only (group A)
Number of subjects: 63
Study: 6994765

Group type: EXPERIMENTAL
Intervention: Guanfacine 1.0 mg intravenously
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 6670282

Group type: EXPERIMENTAL
Intervention: Chloroquine diphosphate (25 mg and 50 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chloroquine diphosphate (above 100 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Chloroquine diphosphate (C1Q)
Number of subjects: 8
Study: 30620668

Group type: EXPERIMENTAL
Intervention: pembrolizumab 200 mg every 3 weeks for up to 2 years
Number of subjects: 305

Group type: COMPARATOR
Intervention: platinum-based chemotherapy (four to six cycles)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: pembrolizumab (after crossover from chemotherapy)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: pembrolizumab
Number of subjects: 305

Group type: COMPARATOR
Intervention: chemotherapy
Number of subjects: 305
Study: 29754417

Group type: EXPERIMENTAL
Intervention: Peer teaching
Number of subjects: 88

Group type: COMPARATOR
Intervention: Video PBLS lesson
Number of subjects: 88
Study: 27289488

Group type: EXPERIMENTAL
Intervention: Fixed low dose of low-molecular-weight heparin (LMWH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intermediate dose of low-molecular-weight heparin (LMWH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 24131674

Group type: EXPERIMENTAL
Intervention: EU paricalcitol dosing regimen (initial μg dose based on iPTH/80)
Number of subjects: 216

Group type: COMPARATOR
Intervention: US paricalcitol dosing regimen (initial dose of 0.04 μg/kg)
Number of subjects: 216
Study: 22492669

Group type: EXPERIMENTAL
Intervention: Short message service maintenance treatment (SMSMT) for 9 months
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Short message service maintenance treatment (SMSMT)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 141
Study: 19733912

Group type: EXPERIMENTAL
Intervention: Acute phase cognitive therapy (A‐CT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Assessment only control
Number of subjects: 84
Study: 18478278

Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg intramuscularly (arm A)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Ondansetron 16 mg orally (arm B)
Number of subjects: 89
Study: 15955118

Group type: COMPARATOR
Intervention: Nicotine 0 mg + Caffeine 0 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicotine 1 mg + Caffeine 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicotine 1 mg + Caffeine 100 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicotine 2 mg + Caffeine 50 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicotine 2 mg + Caffeine 100 mg
Number of subjects: 12
Study: 12061413

Group type: EXPERIMENTAL
Intervention: Classroom cognitive‐behavioral treatment (CBT)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Home‐based audio relaxation treatment (HART)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Delayed‐treatment control
Number of subjects: 38
Study: 10067573

Group type: EXPERIMENTAL
Intervention: New instruments for measuring sleep patterns
Number of subjects: 0
Study: 7668036

Group type: EXPERIMENTAL
Intervention: Adsorbed DT vaccine (n = 51)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Fluid DT vaccine (n = 53)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 104
Study: 2206782

Group type: EXPERIMENTAL
Intervention: 200 mg dipyridamole
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: 25 mg acetylsalicylic acid
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combination of dipyridamole and acetylsalicylic acid
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 7192617

Group type: EXPERIMENTAL
Intervention: Experimental group (subjected to 'conflict' 2 h daily for 12 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Restraint control (placed in conditioning cages but not subjected to conflict)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Maturation control (neither restrained nor stressed)
Number of subjects: 18
Study: 31034352

Group type: EXPERIMENTAL
Intervention: Bulk-fill restorative RBCs (Filtek Bulk‐Fill Restorative, Tetric N Ceram Bulk‐Fill, Beautifil Bulk-fill Restorative)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Bulk-fill flowable RBCs (Filtek Bulk‐Fill Flowable, Tetric N Flow Bulk‐Fill, Beautifil Bulk-Fill Flowable)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Conditioning in air
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Conditioning in ethanol
Number of subjects: 30
Study: 31307254

Group type: EXPERIMENTAL
Intervention: Dispogel
Number of subjects: 77

Group type: COMPARATOR
Intervention: Cathejell
Number of subjects: 77
Study: 28166324

Group type: EXPERIMENTAL
Intervention: Intensive treatment with a systolic BP target of less than 120 mm Hg (n = 1317)
Number of subjects: 2636

Group type: COMPARATOR
Intervention: Standard treatment with a BP target of less than 140 mm Hg (n = 1319)
Number of subjects: 2636

Group type: EXPERIMENTAL
Intervention: Intensive treatment
Number of subjects: 2636

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 2636
Study: 26291900

Group type: EXPERIMENTAL
Intervention: Targeted fluid minimization (TFM)
Number of subjects: 82
Study: 23612453

Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg per day until progression or unacceptable toxicity
Number of subjects: 44
Study: 21942502

Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Post-therapy communication changes
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Post-therapy levels of problem solving and changes in wives' positivity
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Observed communication improvements
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Positivity results
Number of subjects: 134
Study: 18295441

Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Stripping
Number of subjects: 100
Study: 17141087

Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microelectrode (cutting mode)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Microelectrode (coagulation mode)
Number of subjects: 40
Study: 14578410

Group type: EXPERIMENTAL
Intervention: Lomerizine 0.1 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lomerizine 0.3 mg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Lomerizine 5 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10785219

Group type: EXPERIMENTAL
Intervention: 1 mM glucose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5.56 mM glucose
Number of subjects: 0
Study: 9049040

Group type: EXPERIMENTAL
Intervention: Strippings (1, 3, and 5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strippings (3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strippings (1 to 5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strippings (3 and 5)
Number of subjects: 0
Study: 8279682

Group type: EXPERIMENTAL
Intervention: Weak ultrasonication of ethanol solutions (40 kHz, 12 mW, 1 week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treated aqueous ethanol solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treated solutions
Number of subjects: 0
Study: 2881574

Group type: COMPARATOR
Intervention: Org 2305 15 mg (O 15)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Org 2305 30 mg (O 30)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Org 2305 60 mg (O 60)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Diazepam 15 mg (DZ)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30285177

Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (APM)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Physical therapy (PT)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: APM
Number of subjects: 321

Group type: COMPARATOR
Intervention: PT
Number of subjects: 321
Study: 26259568

Group type: EXPERIMENTAL
Intervention: Interactive bi-directional remote monitoring system (Motiva®)
Number of subjects: 621

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 621
Study: 23622766

Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 21940598

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 90
Study: 18463885

Group type: EXPERIMENTAL
Intervention: Treatment started within the first hour after AAT (Group A, 20 patients)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Treatment started more than 1 hour later and less than 16 hours after AAT (Group B, 17 patients)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Treatment started after 24 hours or more (Group C, 15 patients)
Number of subjects: 52
Study: 16612257

Group type: EXPERIMENTAL
Intervention: Sodium intake of 350 mmol/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Sodium intake of 50 mmol/day
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Enalapril administration for 3 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group with essential hypertension
Number of subjects: 11
Study: 14640502

Group type: EXPERIMENTAL
Intervention: Flocculant-disinfectant
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Flocculant-disinfectant plus vessel
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Bleach
Number of subjects: 492

Group type: EXPERIMENTAL
Intervention: Bleach plus vessel
Number of subjects: 492

Group type: COMPARATOR
Intervention: Control
Number of subjects: 492
Study: 10769011

Group type: EXPERIMENTAL
Intervention: GI5402
Number of subjects: 0
Study: 8634010

Group type: EXPERIMENTAL
Intervention: Panic disorder patients
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Panic disorder patients with low frequency of panic attacks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Panic disorder patients with high frequency of panic attacks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 20
Study: 1345129

Group type: EXPERIMENTAL
Intervention: Videotape instruction and feedback (videotherapy)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 31
Study: 3870921

Group type: EXPERIMENTAL
Intervention: Appointment reminder cards and telephone calls to reschedule missed appointments
Number of subjects: 973

Group type: COMPARATOR
Intervention: Nonintervention control group
Number of subjects: 973
Study: 30445644

Group type: EXPERIMENTAL
Intervention: Free-play intervention allowing unrestricted access to outdoor areas for active play.
Number of subjects: 231

Group type: COMPARATOR
Intervention: Control group with usual scheduled periods of outdoor play.
Number of subjects: 231
Study: 30066385

Group type: EXPERIMENTAL
Intervention: Nicotine pre-loading (4 weeks of 21 mg nicotine patch use prior to quitting)
Number of subjects: 1792

Group type: COMPARATOR
Intervention: Standard smoking cessation medications with behavioral support
Number of subjects: 1792
Study: 27213492

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Addiction Treatment (MBAT)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Cognitive Behavioral Treatment (CBT)
Number of subjects: 412

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 412
Study: 25265494

Group type: EXPERIMENTAL
Intervention: vemurafenib and cobimetinib (combination group)
Number of subjects: 495

Group type: COMPARATOR
Intervention: vemurafenib and placebo (control group)
Number of subjects: 495
Study: 22795495

Group type: EXPERIMENTAL
Intervention: Self-monitoring (food journal completion)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Skipping meals
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Eating out for lunch (at least once a week)
Number of subjects: 123
Study: 20635018

Group type: EXPERIMENTAL
Intervention: Detailed sheet (full disclosure of risks)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Brief sheet (brief information on procedure-related risks)
Number of subjects: 106
Study: 18204391

Group type: EXPERIMENTAL
Intervention: Standard NSAIDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cox-2 NSAIDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mobilization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second model with effectiveness data
Number of subjects: 0
Study: 15878289

Group type: EXPERIMENTAL
Intervention: Double-leg semisquat exercise with maximum hip adduction isometric contraction (DLSS-HA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Double-leg semisquat exercise without hip adduction (DLSS)
Number of subjects: 20
Study: 11961033

Group type: EXPERIMENTAL
Intervention: Increased peritoneal clearance of small solutes to adequacy targets recommended by KDOQI
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard peritoneal clearance)
Number of subjects: 0
Study: 10517693

Group type: EXPERIMENTAL
Intervention: 0.1% hydrocortisone butyrate in an oil-in-water emulsion (Locoid Crelo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.05% betamethasone 17-21 dipropionate lotion (Diprosone lotion)
Number of subjects: 0